The Vanguard View - Volume IV
Volume IV
What's New in the Lab Industry Today?
This study compares the sensitivity of MTS and saliva specimens for detecting SARS-CoV-2 by actively following close contacts of COVID-19 cases and collecting MTS and saliva samples for real-time reverse transcription PCR during their postexposure quarantine period.
Natalie Carfora reflects on challenges associated with successfully attaining positive medical policy and contracting for reimbursement for laboratory-developed tests. This results in considerations needed in order to develop a market access strategy. Read along as she discusses strategic market access considerations for laboratory-developed tests.
More job openings exist today for sub-specialized pathologists than any time in the past two decades. Job openings have climbed from 400 in January 2021 to 715 as of April 2021. Inflation paired with an extremely high increase in demand for sub-specialized pathologists and pathology residents means that we have arrived at a place of imbalance in the job market.
领英推荐
The global liver cancer diagnostics market growth is driven by the rising prevalence of liver cancer and increasing R&D investments in the development of novel diagnostic testing. The laboratory held the largest market share in 2021 and is expected to rise.
COVID-19 Billing Tips from Galina Golub of Innovative Lab Solutions
Clinical laboratories performing COVID-19 tests for uninsured patients are no longer able to submit claims for reimbursement. Here are some things your lab should be focusing on to get claims paid:
Contact Us:
(973) 756 - 5080